STOCK TITAN

[Form 4] Ecolab, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Confluent, Inc. (CFLT) – Form 144 Notice of Proposed Sale

On 07/02/2025 an affiliate of Confluent filed a Form 144 indicating the intention to sell up to 242,501 common shares, representing roughly 0.07 % of the company’s 340,389,876 shares outstanding. The planned broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York. Based on the market price used in the filing, the prospective sale is valued at $6.23 million.

The shares were acquired the same day (07/02/2025) via a stock-option exercise, with cash used to cover the exercise price. The filer—identified in prior sales data within the notice as Melanie Vinson—has sold stock in two prior transactions during the last three months: 13,937 shares on 05/22/2025 for $304,662.82 and 14,087 shares on 05/20/2025 for $307,476.95, together totaling 28,024 shares and $612,140 in gross proceeds.

Key takeaways for investors

  • Form 144 filings announce a proposed—not yet executed—sale; actual sales may differ.
  • The number of shares is immaterial to the company’s float but notable for tracking insider sentiment.
  • The stock-option exercise increases the share count by an equal amount, but the dilution impact is de-minimis at the company level.

While the filing signals insider intent to monetize holdings, the relatively small percentage of outstanding shares suggests limited direct market impact. No undisclosed adverse information was asserted by the filer, as required by Rule 144.

Confluent, Inc. (CFLT) – Avviso di Proposta di Vendita Modulo 144

Il 02/07/2025 un affiliato di Confluent ha presentato un Modulo 144 indicando la volontà di vendere fino a 242.501 azioni ordinarie, pari a circa lo 0,07% delle 340.389.876 azioni in circolazione della società. Il broker previsto è Morgan Stanley Smith Barney LLC, Executive Financial Services, New York. In base al prezzo di mercato indicato nel modulo, la vendita potenziale è valutata a 6,23 milioni di dollari.

Le azioni sono state acquisite lo stesso giorno (02/07/2025) tramite esercizio di opzioni su azioni, con liquidità utilizzata per coprire il prezzo di esercizio. Il dichiarante — identificato nei dati di vendite precedenti nel modulo come Melanie Vinson — ha venduto azioni in due transazioni negli ultimi tre mesi: 13.937 azioni il 22/05/2025 per 304.662,82 dollari e 14.087 azioni il 20/05/2025 per 307.476,95 dollari, per un totale di 28.024 azioni e 612.140 dollari di ricavi lordi.

Punti chiave per gli investitori

  • Le presentazioni del Modulo 144 annunciano una vendita proposta — non ancora eseguita —; le vendite effettive potrebbero variare.
  • Il numero di azioni è irrilevante rispetto al flottante della società ma utile per monitorare il sentiment degli insider.
  • L’esercizio delle opzioni aumenta il numero di azioni in circolazione nella stessa misura, ma l’impatto diluitivo è minimo a livello societario.

Pur indicando l’intenzione degli insider di monetizzare le proprie partecipazioni, la percentuale relativamente bassa delle azioni in circolazione suggerisce un impatto diretto limitato sul mercato. Il dichiarante non ha segnalato informazioni negative non divulgate, come richiesto dalla Regola 144.

Confluent, Inc. (CFLT) – Aviso de Venta Propuesta Formulario 144

El 02/07/2025, un afiliado de Confluent presentó un Formulario 144 indicando la intención de vender hasta 242,501 acciones ordinarias, que representan aproximadamente el 0,07 % de las 340,389,876 acciones en circulación de la compañía. El corredor planificado es Morgan Stanley Smith Barney LLC, Executive Financial Services, Nueva York. Según el precio de mercado utilizado en la presentación, la venta potencial está valorada en 6,23 millones de dólares.

Las acciones fueron adquiridas el mismo día (02/07/2025) mediante el ejercicio de opciones sobre acciones, utilizando efectivo para cubrir el precio de ejercicio. El declarante — identificado en datos previos de ventas dentro del aviso como Melanie Vinson — ha vendido acciones en dos transacciones durante los últimos tres meses: 13,937 acciones el 22/05/2025 por 304,662.82 dólares y 14,087 acciones el 20/05/2025 por 307,476.95 dólares, sumando un total de 28,024 acciones y 612,140 dólares en ingresos brutos.

Puntos clave para los inversores

  • Las presentaciones del Formulario 144 anuncian una venta propuesta — aún no ejecutada —; las ventas reales pueden variar.
  • El número de acciones es insignificante para el flotante de la empresa pero relevante para seguir el sentimiento de los insiders.
  • El ejercicio de opciones incrementa el número de acciones en igual medida, pero el impacto dilutivo es mínimo a nivel de la empresa.

Aunque la presentación señala la intención de los insiders de monetizar sus participaciones, el porcentaje relativamente pequeño de acciones en circulación sugiere un impacto directo limitado en el mercado. El declarante no afirmó información adversa no divulgada, como exige la Regla 144.

Confluent, Inc. (CFLT) – 제안된 매도 통지서(Form 144)

2025년 7월 2일, Confluent의 계열사가 Form 144를 제출하여 최대 242,501주의 보통주 매도 의사를 밝혔으며, 이는 회사의 발행 주식 340,389,876주의 약 0.07%에 해당합니다. 예정된 중개인은 Morgan Stanley Smith Barney LLC, Executive Financial Services, 뉴욕입니다. 제출서에 사용된 시가를 기준으로, 예상 매도 가치는 623만 달러입니다.

해당 주식은 같은 날(2025년 7월 2일) 주식 옵션 행사로 취득되었으며, 행사가격 지급을 위해 현금이 사용되었습니다. 제출자는 과거 매도 내역에서 Melanie Vinson으로 확인되며, 지난 3개월 동안 두 차례 매도했습니다: 2025년 5월 22일에 13,937주를 304,662.82달러에, 5월 20일에 14,087주를 307,476.95달러에 매도해 총 28,024주와 612,140달러의 총수익을 기록했습니다.

투자자를 위한 주요 내용

  • Form 144 제출은 제안된 매도를 알리는 것으로, 아직 실행되지 않은 상태이며 실제 매도는 다를 수 있습니다.
  • 주식 수는 회사의 유통 주식 수에 비해 미미하지만 내부자 심리 추적에 중요합니다.
  • 주식 옵션 행사는 동일한 수만큼 주식 수를 증가시키지만, 회사 차원의 희석 영향은 미미합니다.

제출서는 내부자의 보유 지분 현금화 의도를 나타내지만, 발행 주식 대비 상대적으로 적은 비율로 인해 시장에 미치는 직접적인 영향은 제한적입니다. 제출자는 Rule 144에 따라 공개되지 않은 부정적 정보를 주장하지 않았습니다.

Confluent, Inc. (CFLT) – Avis de vente proposée selon le formulaire 144

Le 02/07/2025, un affilié de Confluent a déposé un formulaire 144 indiquant l'intention de vendre jusqu'à 242 501 actions ordinaires, représentant environ 0,07 % des 340 389 876 actions en circulation de la société. Le courtier prévu est Morgan Stanley Smith Barney LLC, Executive Financial Services, New York. Sur la base du prix du marché mentionné dans le dépôt, la vente potentielle est évaluée à 6,23 millions de dollars.

Les actions ont été acquises le même jour (02/07/2025) via l'exercice d'options sur actions, avec des liquidités utilisées pour couvrir le prix d'exercice. Le déposant — identifié dans les données de ventes précédentes dans l'avis comme Melanie Vinson — a vendu des actions lors de deux transactions au cours des trois derniers mois : 13 937 actions le 22/05/2025 pour 304 662,82 $ et 14 087 actions le 20/05/2025 pour 307 476,95 $, totalisant 28 024 actions et 612 140 $ de produits bruts.

Points clés pour les investisseurs

  • Les dépôts du formulaire 144 annoncent une vente proposée — pas encore réalisée — ; les ventes réelles peuvent différer.
  • Le nombre d'actions est négligeable par rapport au flottant de la société mais utile pour suivre le sentiment des initiés.
  • L'exercice des options augmente le nombre d'actions dans la même proportion, mais l'impact dilutif est minime au niveau de l'entreprise.

Bien que le dépôt signale l'intention des initiés de monétiser leurs participations, le pourcentage relativement faible d'actions en circulation suggère un impact direct limité sur le marché. Le déposant n'a pas déclaré d'informations défavorables non divulguées, conformément à la règle 144.

Confluent, Inc. (CFLT) – Mitteilung über geplanten Verkauf gemäß Formular 144

Am 02.07.2025 reichte ein verbundenes Unternehmen von Confluent ein Formular 144 ein, das die Absicht zum Verkauf von bis zu 242.501 Stammaktien angibt, was etwa 0,07 % der insgesamt 340.389.876 ausstehenden Aktien des Unternehmens entspricht. Der geplante Broker ist Morgan Stanley Smith Barney LLC, Executive Financial Services, New York. Basierend auf dem im Formular verwendeten Marktpreis wird der potenzielle Verkauf auf 6,23 Millionen US-Dollar geschätzt.

Die Aktien wurden am selben Tag (02.07.2025) durch Ausübung von Aktienoptionen erworben, wobei Bargeld zur Deckung des Ausübungspreises verwendet wurde. Der Einreicher – in früheren Verkaufsdaten im Hinweis als Melanie Vinson identifiziert – hat in den letzten drei Monaten zwei Verkäufe getätigt: 13.937 Aktien am 22.05.2025 für 304.662,82 US-Dollar und 14.087 Aktien am 20.05.2025 für 307.476,95 US-Dollar, zusammen 28.024 Aktien mit Bruttoerlösen von 612.140 US-Dollar.

Wichtige Erkenntnisse für Investoren

  • Formular 144-Anmeldungen kündigen einen geplanten – noch nicht ausgeführten – Verkauf an; tatsächliche Verkäufe können abweichen.
  • Die Anzahl der Aktien ist für den Streubesitz des Unternehmens unerheblich, aber wichtig zur Nachverfolgung der Insider-Stimmung.
  • Die Ausübung von Aktienoptionen erhöht die Anzahl der Aktien um denselben Betrag, jedoch ist die Verwässerung auf Unternehmensebene minimal.

Obwohl die Anmeldung die Absicht der Insider signalisiert, Bestände zu monetarisieren, deutet der relativ geringe Anteil der ausstehenden Aktien auf eine begrenzte direkte Marktwirkung hin. Der Einreicher hat keine nicht offengelegten negativen Informationen gemäß Regel 144 angegeben.

Positive
  • None.
Negative
  • Insider intent to sell 242,501 shares ($6.23 M) may be viewed as a mild negative sentiment signal despite immaterial dilution.

Insights

TL;DR: Routine Form 144 shows insider aims to sell $6.2 M in stock—size immaterial, sentiment slightly negative.

The proposed sale equals 0.07 % of shares outstanding, so supply pressure should be negligible. However, consecutive insider liquidations within the past quarter indicate ongoing profit-taking following option exercises. Because Form 144 is only a notice, the sale may occur piecemeal or be withheld if market conditions change. From a valuation standpoint, dilution is minimal and does not affect per-share metrics. I view the filing as neutral for fundamentals but a minor negative signal for sentiment.

TL;DR: Standard compliance filing; insider selling pattern worth monitoring, but governance risk low.

Rule 144 requires affiliates to pre-announce sizable open-market sales. The filer certified no material non-public information, satisfying governance best practices. The option-exercise-plus-sale structure is common for liquidity and tax obligations. Aggregate insider sales over three months (≈270 K shares including proposed) remain well below Rule 144 volume limits, indicating adherence to regulatory thresholds. Unless the pace accelerates or multiple executives join in, the governance impact is not material.

Confluent, Inc. (CFLT) – Avviso di Proposta di Vendita Modulo 144

Il 02/07/2025 un affiliato di Confluent ha presentato un Modulo 144 indicando la volontà di vendere fino a 242.501 azioni ordinarie, pari a circa lo 0,07% delle 340.389.876 azioni in circolazione della società. Il broker previsto è Morgan Stanley Smith Barney LLC, Executive Financial Services, New York. In base al prezzo di mercato indicato nel modulo, la vendita potenziale è valutata a 6,23 milioni di dollari.

Le azioni sono state acquisite lo stesso giorno (02/07/2025) tramite esercizio di opzioni su azioni, con liquidità utilizzata per coprire il prezzo di esercizio. Il dichiarante — identificato nei dati di vendite precedenti nel modulo come Melanie Vinson — ha venduto azioni in due transazioni negli ultimi tre mesi: 13.937 azioni il 22/05/2025 per 304.662,82 dollari e 14.087 azioni il 20/05/2025 per 307.476,95 dollari, per un totale di 28.024 azioni e 612.140 dollari di ricavi lordi.

Punti chiave per gli investitori

  • Le presentazioni del Modulo 144 annunciano una vendita proposta — non ancora eseguita —; le vendite effettive potrebbero variare.
  • Il numero di azioni è irrilevante rispetto al flottante della società ma utile per monitorare il sentiment degli insider.
  • L’esercizio delle opzioni aumenta il numero di azioni in circolazione nella stessa misura, ma l’impatto diluitivo è minimo a livello societario.

Pur indicando l’intenzione degli insider di monetizzare le proprie partecipazioni, la percentuale relativamente bassa delle azioni in circolazione suggerisce un impatto diretto limitato sul mercato. Il dichiarante non ha segnalato informazioni negative non divulgate, come richiesto dalla Regola 144.

Confluent, Inc. (CFLT) – Aviso de Venta Propuesta Formulario 144

El 02/07/2025, un afiliado de Confluent presentó un Formulario 144 indicando la intención de vender hasta 242,501 acciones ordinarias, que representan aproximadamente el 0,07 % de las 340,389,876 acciones en circulación de la compañía. El corredor planificado es Morgan Stanley Smith Barney LLC, Executive Financial Services, Nueva York. Según el precio de mercado utilizado en la presentación, la venta potencial está valorada en 6,23 millones de dólares.

Las acciones fueron adquiridas el mismo día (02/07/2025) mediante el ejercicio de opciones sobre acciones, utilizando efectivo para cubrir el precio de ejercicio. El declarante — identificado en datos previos de ventas dentro del aviso como Melanie Vinson — ha vendido acciones en dos transacciones durante los últimos tres meses: 13,937 acciones el 22/05/2025 por 304,662.82 dólares y 14,087 acciones el 20/05/2025 por 307,476.95 dólares, sumando un total de 28,024 acciones y 612,140 dólares en ingresos brutos.

Puntos clave para los inversores

  • Las presentaciones del Formulario 144 anuncian una venta propuesta — aún no ejecutada —; las ventas reales pueden variar.
  • El número de acciones es insignificante para el flotante de la empresa pero relevante para seguir el sentimiento de los insiders.
  • El ejercicio de opciones incrementa el número de acciones en igual medida, pero el impacto dilutivo es mínimo a nivel de la empresa.

Aunque la presentación señala la intención de los insiders de monetizar sus participaciones, el porcentaje relativamente pequeño de acciones en circulación sugiere un impacto directo limitado en el mercado. El declarante no afirmó información adversa no divulgada, como exige la Regla 144.

Confluent, Inc. (CFLT) – 제안된 매도 통지서(Form 144)

2025년 7월 2일, Confluent의 계열사가 Form 144를 제출하여 최대 242,501주의 보통주 매도 의사를 밝혔으며, 이는 회사의 발행 주식 340,389,876주의 약 0.07%에 해당합니다. 예정된 중개인은 Morgan Stanley Smith Barney LLC, Executive Financial Services, 뉴욕입니다. 제출서에 사용된 시가를 기준으로, 예상 매도 가치는 623만 달러입니다.

해당 주식은 같은 날(2025년 7월 2일) 주식 옵션 행사로 취득되었으며, 행사가격 지급을 위해 현금이 사용되었습니다. 제출자는 과거 매도 내역에서 Melanie Vinson으로 확인되며, 지난 3개월 동안 두 차례 매도했습니다: 2025년 5월 22일에 13,937주를 304,662.82달러에, 5월 20일에 14,087주를 307,476.95달러에 매도해 총 28,024주와 612,140달러의 총수익을 기록했습니다.

투자자를 위한 주요 내용

  • Form 144 제출은 제안된 매도를 알리는 것으로, 아직 실행되지 않은 상태이며 실제 매도는 다를 수 있습니다.
  • 주식 수는 회사의 유통 주식 수에 비해 미미하지만 내부자 심리 추적에 중요합니다.
  • 주식 옵션 행사는 동일한 수만큼 주식 수를 증가시키지만, 회사 차원의 희석 영향은 미미합니다.

제출서는 내부자의 보유 지분 현금화 의도를 나타내지만, 발행 주식 대비 상대적으로 적은 비율로 인해 시장에 미치는 직접적인 영향은 제한적입니다. 제출자는 Rule 144에 따라 공개되지 않은 부정적 정보를 주장하지 않았습니다.

Confluent, Inc. (CFLT) – Avis de vente proposée selon le formulaire 144

Le 02/07/2025, un affilié de Confluent a déposé un formulaire 144 indiquant l'intention de vendre jusqu'à 242 501 actions ordinaires, représentant environ 0,07 % des 340 389 876 actions en circulation de la société. Le courtier prévu est Morgan Stanley Smith Barney LLC, Executive Financial Services, New York. Sur la base du prix du marché mentionné dans le dépôt, la vente potentielle est évaluée à 6,23 millions de dollars.

Les actions ont été acquises le même jour (02/07/2025) via l'exercice d'options sur actions, avec des liquidités utilisées pour couvrir le prix d'exercice. Le déposant — identifié dans les données de ventes précédentes dans l'avis comme Melanie Vinson — a vendu des actions lors de deux transactions au cours des trois derniers mois : 13 937 actions le 22/05/2025 pour 304 662,82 $ et 14 087 actions le 20/05/2025 pour 307 476,95 $, totalisant 28 024 actions et 612 140 $ de produits bruts.

Points clés pour les investisseurs

  • Les dépôts du formulaire 144 annoncent une vente proposée — pas encore réalisée — ; les ventes réelles peuvent différer.
  • Le nombre d'actions est négligeable par rapport au flottant de la société mais utile pour suivre le sentiment des initiés.
  • L'exercice des options augmente le nombre d'actions dans la même proportion, mais l'impact dilutif est minime au niveau de l'entreprise.

Bien que le dépôt signale l'intention des initiés de monétiser leurs participations, le pourcentage relativement faible d'actions en circulation suggère un impact direct limité sur le marché. Le déposant n'a pas déclaré d'informations défavorables non divulguées, conformément à la règle 144.

Confluent, Inc. (CFLT) – Mitteilung über geplanten Verkauf gemäß Formular 144

Am 02.07.2025 reichte ein verbundenes Unternehmen von Confluent ein Formular 144 ein, das die Absicht zum Verkauf von bis zu 242.501 Stammaktien angibt, was etwa 0,07 % der insgesamt 340.389.876 ausstehenden Aktien des Unternehmens entspricht. Der geplante Broker ist Morgan Stanley Smith Barney LLC, Executive Financial Services, New York. Basierend auf dem im Formular verwendeten Marktpreis wird der potenzielle Verkauf auf 6,23 Millionen US-Dollar geschätzt.

Die Aktien wurden am selben Tag (02.07.2025) durch Ausübung von Aktienoptionen erworben, wobei Bargeld zur Deckung des Ausübungspreises verwendet wurde. Der Einreicher – in früheren Verkaufsdaten im Hinweis als Melanie Vinson identifiziert – hat in den letzten drei Monaten zwei Verkäufe getätigt: 13.937 Aktien am 22.05.2025 für 304.662,82 US-Dollar und 14.087 Aktien am 20.05.2025 für 307.476,95 US-Dollar, zusammen 28.024 Aktien mit Bruttoerlösen von 612.140 US-Dollar.

Wichtige Erkenntnisse für Investoren

  • Formular 144-Anmeldungen kündigen einen geplanten – noch nicht ausgeführten – Verkauf an; tatsächliche Verkäufe können abweichen.
  • Die Anzahl der Aktien ist für den Streubesitz des Unternehmens unerheblich, aber wichtig zur Nachverfolgung der Insider-Stimmung.
  • Die Ausübung von Aktienoptionen erhöht die Anzahl der Aktien um denselben Betrag, jedoch ist die Verwässerung auf Unternehmensebene minimal.

Obwohl die Anmeldung die Absicht der Insider signalisiert, Bestände zu monetarisieren, deutet der relativ geringe Anteil der ausstehenden Aktien auf eine begrenzte direkte Marktwirkung hin. Der Einreicher hat keine nicht offengelegten negativen Informationen gemäß Regel 144 angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McKibben Tracy B

(Last) (First) (Middle)
C/O ECOLAB INC.
1 ECOLAB PLACE

(Street)
ST. PAUL MN 55102

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ECOLAB INC. [ ECL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/30/2025 A 126.18 A $0 10,034.73(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 20.11 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.
/s/ Youhao Dong, as Attorney-in-Fact for Tracy B. McKibben 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CFLT shares are proposed for sale in this Form 144?

242,501 common shares are listed for potential sale.

What is the estimated value of the shares noted in the CFLT Form 144 filing?

The aggregate market value disclosed is $6,227,425.68.

When could the proposed CFLT insider sale occur?

The approximate sale date provided is 07/02/2025.

Who is the broker handling the proposed sale for CFLT shares?

The filing names Morgan Stanley Smith Barney LLC, Executive Financial Services.

Does the filing create immediate dilution for CFLT shareholders?

Dilution impact is de-minimis; 242,501 shares equal about 0.07 % of total shares outstanding.

Is this Form 144 a guarantee the CFLT insider will sell?

No. Form 144 is a notice of intent; the insider may sell, postpone, or cancel the transaction.
Ecolab Inc

NYSE:ECL

ECL Rankings

ECL Latest News

ECL Latest SEC Filings

ECL Stock Data

74.63B
282.97M
0.18%
92.61%
0.74%
Specialty Chemicals
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Link
United States
SAINT PAUL